Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Articles: DFG German National Licenses  (4)
  • Insulin receptors  (2)
  • glucose fatty acid cycle  (2)
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Diabetologia 17 (1979), S. 77-84 
    ISSN: 1432-0428
    Keywords: Insulin receptors ; insulin degradation ; glucose and lactate metabolism ; monocytes ; lymphocytes and mononuclear leucocytes
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Insulin binding, insulin degradation and glucose metabolism were studied in highly purified preparations of monocytes. Steady state specific insulin binding was found at 15 °C, whereas no plateau was reached at 37 °C because of considerable insulin degradation at this temperature.125I-insulin nonspecifically bound to monocytes at 15 °C remained constant for 120 min. In contrast non-specifically bound125I-insulin increased during incubation at 37 °C. About one third dissociated slowly to a washout medium suggesting an intracellular uptake of this fraction of non-specifically monocyte bound insulin. Monocytes did not degrade insulin at 15 °C. At 37 °C insulin was degraded partly by “proteases” released from the cells and partly by the specific insulin receptor. We found that about 35% of the total monocyte receptor bound iodoinsulin dissociated to a washout medium as degraded insulin. Furthermore, the degradation velocity of receptor bound insulin was proportional to the receptor occupancy. Thus, at 37 °C receptor bound insulin is the substrate for insulin degradation in monocytes and the reaction between the insulin molecule and the insulin receptor is conceivably considered not to be bimolecular at 37 °C unlike at 15 °C. Previously, no biological effect of insulin on monocytes has been demonstrated. In this study we found that insulin increased glucose uptake (25%, p〈0.01) and lactate release (12%, p〈0.05) in monocytes with ED50-values within the physiological range. To obtain 50% of maximal biological effect it was necessary to activate only a few percent of the receptors.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-0428
    Keywords: Key words Hepatic glucose production ; glucose fatty acid cycle ; Cori cycle ; muscle glucose metabolism ; glycogen synthase.
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Non-insulin-dependent diabetic (NIDDM) patients were studied during a modified euglycaemic state when fasting hyperglycaemia was normalized by a prior (–210 to –150 min) – and later withdrawn (–150–0 min) – intravenous insulin infusion. Glucose metabolism was assessed in NIDDM patients (n = 10) and matched control subjects (n = 10) using tritiated glucose turnover rates, indirect calorimetry and skeletal muscle glycogen synthase activity determinations. Total and non-oxidative exogenous glycolytic flux rates were measured using appearance rates of tritiated water. A + 180 min euglycaemic hyperinsulinaemic (40 mU · m–2· min–1) clamp was performed to determine the insulin responsiveness of the various metabolic pathways. Plasma glucose concentration increased spontaneously during baseline measurements in the NIDDM patients (-120 to 0 min: 4.8 ± 0.3 to 7.0 ± 0.3 mmol/l; p 〈 0.01), and was primarily due to an elevated rate of hepatic glucose production (3.16 ± 0.13 vs 2.51 ± 0.16 mg · kg FFM–1· min–1; p 〈 0.01). In the NIDDM subjects baseline glucose oxidation was decreased (0.92 ± 0.17 vs 1.33 ± 0.14 mg · kg FFM–1· min–1; p 〈 0.01) in the presence of a normal rate of total exogenous glycolytic flux and skeletal muscle glycogen synthase activity. The simultaneous finding of an increased lipid oxidation rate (1.95 ± 0.13 vs 1.61 ± 0.07 mg · kg FFM–1· min–1; p = 0.05) and increased plasma lactate concentrations (0.86 ± 0.05 vs 0.66 ± 0.03 mmol/l; p = 0.01) are consistent with a role for both the glucose-fatty acid cycle and the Cori cycle in the maintenance and development of fasting hyperglycaemia in NIDDM during decompensation. Insulin resistance was demonstrated during the hyperinsulinaemic clamp in the NIDDM patients with a decrease in the major peripheral pathways of intracellular glucose metabolism (oxidation, storage and muscle glycogen synthase activity), but not in the pathway of non-oxidative glycolytic flux which was not completely suppressed during insulin infusion in the NIDDM patients (0.55± 0.15 mg · kg FFM–1· min–1; p 〈 0.05 vs 0; control subjects: 0.17 ± 0.29; NS vs 0). Thus, these data also indicate that the defect(s) of peripheral (skeletal muscle) glucose processing in NIDDM goes beyond the site of glucose transport across the cell membrane. [Diabetologia (1995) 38: 326 –336]
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-0428
    Keywords: Insulin receptors ; monocytes ; glucose tolerance ; insulin sensitivity
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary We have studied in normal man the inter-relationships between insulin binding to monocytes, glucose tolerance and insulin sensitivity. In 25 young healthy persons we found a significant positive correlation between insulin binding and glucose disappearance rate both after glucose (R = 0.68, p〈0.01) and insulin (R = 0.49, p〈0.02) given intravenously.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1432-0428
    Keywords: Hepatic glucose production ; glucose fatty acid cycle ; Cori cycle ; muscle glucose metabolism ; glycogen synthase
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Non-insulin-dependent diabetic (NIDDM) patients were studied during a modified euglycaemic state when fasting hyperglycaemia was normalized by a prior (−210 to −150 min) — and later withdrawn (−150–0 min) — intravenous insulin infusion. Glucose metabolism was assessed in NIDDM patients (n=10) and matched control subjects (n=10) using tritiated glucose turnover rates, indirect calorimetry and skeletal muscle glycogen synthase activity determinations. Total and non-oxidative exogenous glycolytic flux rates were measured using appearance rates of tritiated water. A+180 min euglycaemic hyperinsulinaemic (40 mU·m−2·min−1) clamp was performed to determine the insulin responsiveness of the various metabolic pathways. Plasma glucose concentration increased spontaneously during baseline measurements in the NIDDM patients (−120 to 0 min: 4.8±0.3 to 7.0±0.3 mmol/l; p〈0.01), and was primarily due to an elevated rate of hepatic glucose production (3.16±0.13 vs 2.51±0.16 mg·kg FFM−1·min−1; p〈0.01). In the NIDDM subjects baseline glucose oxidation was decreased (0.92±0.17 vs 1.33±0.14 mg·kg FFM−1·min−1; p〈0.01) in the presence of a normal rate of total exogenous glycolytic flux and skeletal muscle glycogen synthase activity. The simultaneous finding of an increased lipid oxidation rate (1.95±0.13 vs 1.61±0.07 mg·kg FFM−1·min−1; p=0.05) and increased plasma lactate concentrations (0.86±0.05 vs 0.66±0.03 mmol/l; p=0.01) are consistent with a role for both the glucose-fatty acid cycle and the Cori cycle in the maintenance and development of fasting hyperglycaemia in NIDDM during decompensation. Insulin resistance was demonstrated during the hyperinsulinaemic clamp in the NIDDM patients with a decrease in the major peripheral pathways of intracellular glucose metabolism (oxidation, storage and muscle glycogen synthase activity), but not in the pathway of non-oxidative glycolytic flux which was not completely suppressed during insulin infusion in the NIDDM patients (0.55±0.15 mg·kg FFM−1·min−1; p〈0.05 vs 0; control subjects: 0.17±0.29; NS vs 0). Thus, these data also indicate that the defect(s) of peripheral (skeletal muscle) glucose processing in NIDDM goes beyond the site of glucose transport across the cell membrane.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...